Please login to the form below

Not currently logged in
Email:
Password:

EpiPen

This page shows the latest EpiPen news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Biosimilar Herceptin can't make Perjeta cost effective and more

Daily Brief: Biosimilar Herceptin can't make Perjeta cost effective and more

Teva lifted by approval for EpiPen generic. The FDA has approved Teva’s version of Mylan’s EpiPen, making it the first generic competitor to the costly emergency allergy treatment. ... Mylan introduced its own authorised generic form of the EpiPen in

Latest news

  • Making a list and checking it twice… Making a list and checking it twice…

    like that of Mylan and Epipen in 2016 and this theme is poised to continue for the foreseeable future.

  • Mylan facing US anticompetitive practice probe Mylan facing US anticompetitive practice probe

    Two leading members of the US Senate Judiciary Committee have called for an investigation into Mylan's adherence to market competition laws over its EpiPen sales practices. ... In a letter to the federal antitrust regulator, Grassley and Leahy said the

  • Pricing's dodos Pricing's dodos

    And, as I prepared for an interview about my imminent new book, I took the news story about Mylan's EpiPen as an example.

  • EpiDemic EpiDemic

    Getting serious about drug pricing. You're reading this in early October and the EpiPen saga is still raging on this side of the pond. ... And the next egregious drug-pricing headline is yet to come. But like Valeant and Martin Shkreli before it, the

  • Global pharma market forecast to reach $1.12tr by 2022 Global pharma market forecast to reach $1.12tr by 2022

    The recent outcry over Mylan's price increases for EpiPen - followed by the company's repeated capitulations - show just how sensitive pricing models can be to political pressure.

More from news
Approximately 3 fully matching, plus 12 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics